2015
DOI: 10.4238/2015.june.26.5
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of adipogenic differentiation of bone marrow mesenchymal stem cells by erythropoietin via activating ERK and P38 MAPK

Abstract: ABSTRACT. We examined whether erythropoietin (EPO) can inhibit adipogenic differentiation of mesenchymal stem cells (MSCs) in the mouse bone marrow and its underlying mechanism. We separated and extracted mouse bone marrow MSCs and induced adipogenic differentiation using 3-isobutyl-1-methylxanthine, insulin, and dexamethasone. Different concentrations of EPO were added to the cells and observed by Oil Red O staining on the 20th day to quantitatively analyze the degree of cell differentiation. mRNA expression … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
6
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 19 publications
1
6
0
1
Order By: Relevance
“…Despite the negative impact that this cell population may have on bone formation in contact with Ti implant , the effect of Ti surfaces on adipocyte differentiation and/or activity is underexplored, making comparisons of these results with data from the literature difficult or even unfeasible. However, our findings are in agreement, to some extent, with the reduced ERK activity detected during adipogenesis in cultures of the ST2 mouse MSC line, the increased ERK phosphorylation associated with reduced adipocyte differentiation of mouse MSCs, and recovery of the propyl gallate‐inhibiting adipogenic potential of human MSCs in response to ERK blocking .…”
Section: Discussionsupporting
confidence: 89%
“…Despite the negative impact that this cell population may have on bone formation in contact with Ti implant , the effect of Ti surfaces on adipocyte differentiation and/or activity is underexplored, making comparisons of these results with data from the literature difficult or even unfeasible. However, our findings are in agreement, to some extent, with the reduced ERK activity detected during adipogenesis in cultures of the ST2 mouse MSC line, the increased ERK phosphorylation associated with reduced adipocyte differentiation of mouse MSCs, and recovery of the propyl gallate‐inhibiting adipogenic potential of human MSCs in response to ERK blocking .…”
Section: Discussionsupporting
confidence: 89%
“…Moreover, there is data demonstrating that erythropoietin inhibits adipogenic differentiation of bone marrow derived mouse MSCs via activation of ERK (Liu et al 2015). Finally, an inhibitory role has been demonstrated for JNK in both adipogenesis and osteogenesis in human MSCs (Gu et al 2015;Tominaga et al 2005).…”
Section: Discussionmentioning
confidence: 98%
“…The role of p38 MAPK in adipogenesis is still controversial. While some studies have demonstrated that activation of p38 MAPK promotes adipogenesis [ 38 , 39 , 40 ], opposite results have also been reported [ 41 , 42 ]. Studies by Engelman et al and Aouadi et al suggested that p38 MAPK activity may be required in the initial stage of adipogenesis, and that suppression of p38 MAPK may be necessary in the later stage of adipogenesis [ 43 , 44 ].…”
Section: Discussionmentioning
confidence: 99%